DE69232875D1 - MHC-Konjugate zur Verbesserung der Autoimmunität. - Google Patents
MHC-Konjugate zur Verbesserung der Autoimmunität.Info
- Publication number
- DE69232875D1 DE69232875D1 DE69232875T DE69232875T DE69232875D1 DE 69232875 D1 DE69232875 D1 DE 69232875D1 DE 69232875 T DE69232875 T DE 69232875T DE 69232875 T DE69232875 T DE 69232875T DE 69232875 D1 DE69232875 D1 DE 69232875D1
- Authority
- DE
- Germany
- Prior art keywords
- improve autoimmunity
- mhc
- conjugates
- mhc conjugates
- autoimmunity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/690,840 US5260422A (en) | 1988-06-23 | 1991-04-23 | MHC conjugates useful in ameliorating autoimmunity |
US07/869,293 US5468481A (en) | 1988-06-23 | 1992-04-14 | MHC class II-peptide conjugates useful in ameliorating autoimmunity |
PCT/US1992/003391 WO1992018150A1 (en) | 1991-04-23 | 1992-04-23 | Mhc conjugates useful in ameliorating autoimmunity |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69232875D1 true DE69232875D1 (de) | 2003-01-30 |
DE69232875T2 DE69232875T2 (de) | 2003-08-21 |
Family
ID=27104684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69232875T Expired - Fee Related DE69232875T2 (de) | 1991-04-23 | 1992-04-23 | MHC-Konjugate zur Verbesserung der Autoimmunität. |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0630255B1 (de) |
JP (1) | JP2003231698A (de) |
DE (1) | DE69232875T2 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2842570B1 (de) * | 2007-03-07 | 2020-05-06 | UTI Limited Partnership | Zusammensetzungen und verfahren zur prävention und behandlung von autoimmunkrankheiten |
WO2008116468A2 (en) | 2007-03-26 | 2008-10-02 | Dako Denmark A/S | Mhc peptide complexes and uses thereof in infectious diseases |
EP2167537A2 (de) | 2007-07-03 | 2010-03-31 | Dako Denmark A/S | Zusammengestellte verfahren für die analyse und sortierung von proben |
US10611818B2 (en) | 2007-09-27 | 2020-04-07 | Agilent Technologies, Inc. | MHC multimers in tuberculosis diagnostics, vaccine and therapeutics |
DK2254592T3 (da) | 2008-02-28 | 2019-09-09 | Dako Denmark As | MHC-multimerer til Borrelia-diagnostik og sygdom |
US10722562B2 (en) | 2008-07-23 | 2020-07-28 | Immudex Aps | Combinatorial analysis and repair |
GB0817244D0 (en) | 2008-09-20 | 2008-10-29 | Univ Cardiff | Use of a protein kinase inhibitor to detect immune cells, such as T cells |
WO2010037402A1 (en) | 2008-10-02 | 2010-04-08 | Dako Denmark A/S | Molecular vaccines for infectious disease |
US11992518B2 (en) | 2008-10-02 | 2024-05-28 | Agilent Technologies, Inc. | Molecular vaccines for infectious disease |
GB0919751D0 (en) * | 2009-11-11 | 2009-12-30 | King S College Hospital Nhs Fo | Conjugate molecule |
US9511151B2 (en) | 2010-11-12 | 2016-12-06 | Uti Limited Partnership | Compositions and methods for the prevention and treatment of cancer |
US10988516B2 (en) | 2012-03-26 | 2021-04-27 | Uti Limited Partnership | Methods and compositions for treating inflammation |
US9603948B2 (en) | 2012-10-11 | 2017-03-28 | Uti Limited Partnership | Methods and compositions for treating multiple sclerosis and related disorders |
KR20160077202A (ko) | 2013-11-04 | 2016-07-01 | 유티아이 리미티드 파트너쉽 | 지속적 면역요법을 위한 방법 및 조성물 |
BR112017023853A2 (pt) | 2015-05-06 | 2018-07-17 | Uti Limited Partnership | composições de nanopartícula para terapia sustentada. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5194425A (en) * | 1988-06-23 | 1993-03-16 | Anergen, Inc. | Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
IL92629A0 (en) * | 1989-12-10 | 1990-08-31 | Yeda Res & Dev | Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases |
AU3220693A (en) * | 1991-11-19 | 1993-06-15 | Anergen, Inc. | Mhc subunit conjugates useful in ameliorating deleterious immune responses |
-
1992
- 1992-04-23 EP EP92911380A patent/EP0630255B1/de not_active Expired - Lifetime
- 1992-04-23 DE DE69232875T patent/DE69232875T2/de not_active Expired - Fee Related
-
2002
- 2002-07-19 JP JP2002211742A patent/JP2003231698A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0630255B1 (de) | 2002-12-18 |
EP0630255A4 (de) | 1995-04-19 |
EP0630255A1 (de) | 1994-12-28 |
DE69232875T2 (de) | 2003-08-21 |
JP2003231698A (ja) | 2003-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68908909D1 (de) | Kabelbinder. | |
DE69126606D1 (de) | Vakzine | |
DE69317474D1 (de) | Abbaubarer Verbundstoff | |
MX9201770A (es) | Mejoras relacionadas con las secciones de plastificacion. | |
DK0385610T3 (da) | Konjugater | |
DE69114940D1 (de) | Multifunktionsanzeigesystem. | |
DE69232875T2 (de) | MHC-Konjugate zur Verbesserung der Autoimmunität. | |
FI924983A (fi) | Polycykliska konjugat | |
DE59101215D1 (de) | Kabelzugentlastung. | |
FI923238A0 (fi) | Cysteinamid innehaollande permanent. | |
DE59102503D1 (de) | Kanüle. | |
DE59107014D1 (de) | 4-Cyano-3-fluorophenylester. | |
NO921807L (no) | Brennstoffsammensetning | |
DE69105239D1 (de) | Akarizide Zusammensetzung. | |
DE69229694D1 (de) | Verbundwerkstoff | |
DE69300896D1 (de) | Ziele. | |
ITMI921226A1 (it) | Rincalzatrice | |
DE69123256D1 (de) | Antigen-antikörperkonjugaten | |
ATE94266T1 (de) | Kabelbinder. | |
FI742U1 (fi) | Koppling foer kabeln till en svetsbraennare | |
NO920719D0 (no) | Injiserbare s-adenosyl-l-metionin-holdige preparater | |
KR930014523U (ko) | 괘지고리를 형성한 열쇠 | |
ID1028B (id) | Vaksin | |
SE9102907L (sv) | Vaexttraagsystem inklusive delar | |
IS3737A7 (is) | Hraðhrífa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: COULTER PHARMACEUTICAL, INC., SEATTLE, WASH., US |
|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |